|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Leflunomide in psoriatic arthritis:results from a large European prospective observational study显示文摘 | Behrens F Finkenwirth C Pavelka K | 2013 | Arthritis Care Res2013，65，3： | 1 |
| 2 | Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials显示文摘 | Bruyere O Pavelka K Rovati LC | 2008 | Osteoarthritis Cartilage2008，16，2： | 1 |
| 3 | Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3 year, randomized, placebo controlled, double blind study显示文摘 | PAVELKA K GATTEROVA J OLEJAROVA M | 2002 | Arch Intern Med2002，162，18： | 1 |
| 4 | Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment显示文摘 | Pavelka K Gatterova J Tegzova D | 2007 | Clin Exp Rheumatol2007，25，： | 1 |
| 5 | Prospective new biological therapies for rheumatoid arthritis显示文摘 | Venco vsk J Pavelka K Ospelt C | 2009 | Autoimmun Rev2009，9，2： | 1 |
| 6 | Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study显示文摘 | Pavelka K Gatterova J Olejarova M | 2002 | Arch Intern Med2002，162，18： | 1 |
| 7 | EULAR evidence based recommendations for the management of hip osteoarthritis,report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)显示文摘 | Zhang W Doherty M Arden N Bannwarth B Bijlsma J Gunther KP Hauselmann H J Herrero-Beaumont G Jordan K Kaklamanis P Leeb B Lequesne M Lohmander S Mazieres B Martin-Mola E Pavelka K Pendleton A Punzi L Swoboda B Varatojo R Verbruggen G Zimmermann-Gorska Ⅰ D | | 0，，05： | 1 |
| 8 | Complex Analysis of Urate Transporters SLC2A9,SLC22A12 and Functional Characterization of Non-Synonymous Allelic Variants of GLUT9 in the Czech Population:No Evidence of Effect on Hyperuricemia and Gout显示文摘 | Hurba O Mancikova A Krylov V Pavlikova M Pavelka K Stibur- kov fi B | 2014 | PLoS One2014，309，10： | 1 |
| 9 | A review of the effects of prolactin hormone and cytokine on the development and pathogenesis of autoimmune diseases 显示文摘 | Fojtikova M Cerna M Pavelka K | 2010 | Vnitr Lek2010，56，5： | 1 |
| 10 | Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee 显示文摘 | PAVELKA K COSTE P GEHER P | 2010 | Chn Rheumatol2010，29，6： | 1 |
| 11 | Our results of surgical management of unstable pelvic ring injuries显示文摘 | Pavelka T Dzupa V Stulík J | | 0，，01： | 1 |
| 12 | Acute effects of gluco- corticoids on serum markers of osteoclasts, osteoblasts, and os- teocytes 显示文摘 | Brabnikova Maresova K Pavelka K | 2013 | Calcif Tissue Int2013，92，4： | 1 |
| 13 | Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee显示文摘 | Pavelka K Coste P Geher P | 2010 | Clin Rheumato12010，29，6： | 1 |
| 14 | A review of the effects of prolactin hormone and cytokine on the development and pathogenesis of autoimmune diseases显示文摘 | Fojtikova M Cerna M Pavelka K | 2010 | Vnitr Lek2010，56，5： | 1 |
| 15 | Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study显示文摘 | Pavelka K Gatterova J Ole)arova M | 2002 | Arch Intern Med2002，162，18： | 1 |
| 16 | The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee:a randomized,multicenter,double-blind,placebo-controlled study with primary end points at two months after the end of a three-month treatment period显示文摘 | Pavelka K Trc T Karpas K | 2007 | Arthritis Rheum2007，56，12： | 1 |
| 17 | Glucosamine sulfate use and delay of progression of knee osteoarthritis显示文摘 | Pavelka K Gatterova J Marta O | 2002 | Arch Intern Med2002，162，8： | 1 |
| 18 | Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, plaCebo-controlled trials显示文摘 | Bruyere O Pavelka K Rovati LC | 2008 | Osteoarthritis Cartilage2008，16，2： | 1 |
| 19 | Clinical efficacy of etanercept versus sulfasalazine in ankylosing spondylitis subjects with peripheral joint involvement显示文摘 | Braun J Pavelka K Ramos-Remus C | 2012 | The Journal of Rheumatology2012，39，4： | 1 |
| 20 | Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study显示文摘 | Pavelka K Szekaneez Z Damjanov N | 2013 | Clin Rheumatol2013，32，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员